In contrast, two researchers connected with A to Z defended the results, asserting in interviews that the study fell just short of statistical significance and describing the results as new evidence that patients who have suffered heart attacks should take powerful doses of cholesterol-lowering drugs.

FORBES: Cholesterol Study Poses Dangers For Merck